CoChat

Effectiveness of Florbetapir PET Imaging in Changing Patient Management

Open access
Pontecorvo, Michael J., Siderowf, Andrew, Dubois, Bruno, Doraiswamy, P. Murali, Frisoni, Giovanni B., Grundman, Michael, Nobili, Flavio, Sadowsky, Carl H., Salloway, Stephen, Arora, Anupa K., Chevrette, Antoine, Deberdt, Walter, Dell'Agnello, Grazia, Flitter, Matthew, Galante, Nick, Lowrey, Mark J., Lu, Ming, McGeehan, Anne, Devous Sr., Michael D., Mintun, Mark A. · 2017 · Dementia and Geriatric Cognitive Disorders
Cited by 46

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Aims: To evaluate the impact of amyloid PET imaging on diagnosis and patient management in a multicenter, randomized, controlled study. Methods: Physicians identified patients seeking a diagnosis for mild cognitive impairment or dementia, possibly due to Alzheimer disease (AD), and recorded a working diagnosis and a management plan. The patients underwent florbetapir PET scanning and were randomized to either immediate or delayed (1-year) feedback regarding amyloid status. At the 3-month visit, the physician updated the diagnosis and recorded a summary of the actual patient management since the post-scan visit. The study examined the impact of immediate versus delayed feedback on patient diagnosis/management at 3 and 12 months. Results: A total of 618 subjects were randomized (1:1) to immediate or delayed feedback arms, and 602 subjects completed the 3-month primary endpoint visit. A higher proportion of patients in the immediate feedback arm showed a change in diagnosis compared to the controls (32.6 vs. 6.4%; p = 0.0001). Similarly, a higher proportion of patients receiving immediate feedback had a change in management plan (68 vs. 55.5%; p < 0.002), mainly driven by changes in AD medication. Specifically, acetylcholinesterase inhibitors were prescribed to 67% of the amyloid-positive and 27% of the amyloid-negative subjects in the information group compared with 56 and 43%, respectively, in the control group (p < 0.0001). These between-group differences persisted until the 12-month visit. Conclusion: Knowledge of the amyloid status affects the diagnosis and alters patient management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000478007

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 46

Metadata

Authors
Pontecorvo, M. J., Siderowf, A., Dubois, B., Doraiswamy, P. M., Frisoni, G. B., Grundman, M., Nobili, F., Sadowsky, C. H., Salloway, S., Arora, A. K., Chevrette, A., Deberdt, W., Dell'Agnello, G., Flitter, M., Galante, N., Lowrey, M. J., Lu, M., McGeehan, A., Devous Sr., M. D., & Mintun, M. A.
Venue
Dementia and Geriatric Cognitive Disorders
Publisher
S. Karger AG
Published
2017
Volume
44
Issue
3-4
Pages
129-143
ISSN
  • 1420-8008 (ISSN-L)
  • 1421-9824
OpenAlex
W2742954524
Cited by
46
References
16
FWCI
4.18
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.